Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand

• Published in: BMC public health Vol. 8; no. 1; p. 245
• Main Authors: Sirinak, Chawin, Kittikraisak, Wanitchaya, Pinjeesekikul, Duangporn, Charusuntonsri, Pricha, Luanloed, Phinai, Srisuwanvilai, La-ong, Nateniyom, Sriprapa, Akksilp, Somsak, Likanonsakul, Sirirat, Sattayawuthipong, Wanchai, Burapat, Channawong, Varma, Jay K
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.07.2008; BioMed Central; BMC
• Subjects: Adolescent; Adult; AIDS-Related Opportunistic Infections - drug therapy; Anti-Retroviral Agents - therapeutic use; Antitubercular Agents - adverse effects; Antitubercular Agents - therapeutic use; Biomarkers - blood; Care and treatment; Cohort Studies; Complications and side effects; Diagnosis; Female; Hepatitis B - complications; Hepatitis B - diagnosis; Hepatitis B Surface Antigens - blood; Hepatitis C - complications; Hepatitis C - diagnosis; Hepatitis C Antibodies - blood; Hepatitis C virus; Hepatitis, Viral; HIV infection; HIV Infections - complications; HIV Infections - drug therapy; Humans; Logistic Models; Male; Mycobacterium; Observation; Risk Factors; Serologic Tests; Thailand; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary - complications; Tuberculosis, Pulmonary - drug therapy; Thailand; Thailand, Chacoengsao Prov., Bangkok

The occurrence of tuberculosis (TB), human immunodeficiency virus (HIV), and viral hepatitis infections in the same patient poses unique clinical and public health challenges, because medications to treat TB and HIV are hepatotoxic. We conducted an observational study to evaluate risk factors for HB...